Inergetics Inc (fka NRTI)

[crookedneck]

What NRTI Investors really need to understand!

I agree with you wholeheartedly that you should not trust anyone down here in OTC land, but Mr. James is unlike any CEO you will find down here and the reason I have come to trust him and believe in him are due to his operating principals and his accomplishments to date to turn this company around. He and his management team have been here for 2 years now and trust is something you earn, which is the case here and the only exception I have ever found in the OTC markets.

The fact is he hasn't and will not share any information that could be construed as insider information and he hasn't made any statements that he hasn't been able to back up. Have you seen a single prediction, estimate, or promise that came from Mr. James that did not happen? That is not how he works, he won't make bold predictions or outlandish promises in an attempt to draw new investors. This is the reason we always hear about these new deals and news after they happen. He made it very clear that he will not state anything unless he is absolutely sure it will happen.

Trust is something that has to earned on an ongoing basis and what he and his team have accomplished speaks volumes about why he has earned my trust to date! Now compare this to what you usually see in this corrupt OTC exchange that is filled with those other CEO's who utilize paid pumps, fluff PR's, big promises that never materialize, and reverse splits to simply line their pockets and support their lifestyles without ever accomplishing anything. Remember, he hired a respectable IR firm, RLM Finsbury, to handle their public relations, unlike previous management. You won't ever see any of these unsavory tactics with Mr. James at the helm and that is a fact that will continue to be supported from every angle.

You also need only to take a close look at his past history to see that he has never been involved in any suspicious activity or been involved in any unsavory dealings. At the same time you need to examine his accomplishments and successes to see why I believe in him and his business plan to turn this company around.

At this early stage it is to be expected that we will see some dilution along the way, but Mr. James has been doing this as responsible as he can and will be completely open about it. He said "If anyone knows where he can get better financing he is all ears and if anyone thinks he is not doing his job as CEO, he would like to hear what it is along with a better solution". He is very serious about this and he is working his best to make this all happen, but you can only do so much in a certain amount of time and you have to realistic about the business and what it takes to make it all work.

Since taking over 2 years ago, Mr. James and his leadership team have accomplished the following, which again, speaks volumes about how he operates and what he can accomplish:

* Reformulated the entire Surgex line. Along with enlisting upcoming athletes to endorse and help market the brand, such as Surgex Sports Nutrition Spokesperson Keenan Allen of the San Diego Chargers - Named NFL Offensive Rookie of the Year. Not to mention that Surgex is also the preferred sports nutrition brand for Army Sports.

* Launched an exclusive, high performance, private label protein shake for Muscle Maker Grill – one of the fastest growing health food franchises in the U.S. The private label shake which is currently shipping, carries the Muscle Maker Grill "42" moniker. It comes in three great tasting flavors – Vanilla, Chocolate and Strawberry - and will be available for sale at all 70 Muscle Maker Grill franchises on March 1st. Under the agreement, Inergetics will supply an estimated 600,000 shakes to Muscle Maker Grill franchises over the next 12 months. Inergetics also worked in partnership with Muscle Maker Grill to develop a custom product design, as well as an online ordering system for its franchisees.

* Created the Martha Stewart Essentials line and brokered a deal with Martha Stewart to bring it all together. Then sold the entire line into Walgreen's that forced distribution to all their stores across the US to kick things off. Not to mention the distribution across other chains and numerous online vendors, with much more in the works, such as Cardinal Health, announced today.

* Bought the Bikini Ready & Slim Trim brands and developed a National marketing plan with well known women surfer's to help endorse and market the brand across the US. As well as getting new distribution at retail chains and online stores. The Bikini Ready brand is quickly gaining popularity through social media and off to great start, with Slim Trim trailing along as an economical alternative.

* Relocated the company to the Innovation Zone of Newark, NJ to receive cash after fees of over $5 million net to date from the New Jersey Technology Business Tax Certificate Transfer Program. This state funding was non-dilutive and did not add shares or debt to the capital structure of the company. This funding was reinvested into the business to help expand its product offerings and achieve greater distribution of its existing product lines.

* Acquired the Intrinsix brand and developed a distribution agreement with Podiatree to sell the brand at their locations across the US without the need to spend any promotional dollars.

* Acquired OmEssentials, a private company dedicated to the development of advanced nutritional formulations and progressive nutrition education supporting the yoga, wellness and health food industries. The strategic purchase allows for expansion into new markets and continued diversification of their nutritional supplements.

* Entered into Strategic Partnership with Terra Tech Corporation to Develop a New Line of Hemp Oil-Based Nutritional Supplements.

* Created their own Scientific/Medical Advisory Board to help guide in the formulation of the proprietary line of natural Cannabidiol (CBD)-based nutritional supplements. They were able to recruit some of the best minds in the medical marijuana industry that have studied and worked in the field for a very long time and well admired by their peers. The ability to assemble such an all star cast with such extensive credentials to help create and endorse these supplements is something NONE of the other MJ companies have even attempted, making this approach very exclusive and give this partnership a huge competitive advantage that will be unmatched in the MJ supplement market. They are:

Dr. Yu Shao, who has extensive experience in product research and development across many areas of health and wellness, specializing in pharmaceutical extraction methods and plant biochemistry – as well as formulating herbal and botanical nutritional products. He brings almost two decades of expertise in these fields working with a variety of global firms, including Glaxo Smith Kline, Wyeth (now Pfizer), and Merck, directing the launch of more than 30 innovative new products for these companies.

Dr. Joseph McSherry who is a Neurologist who has extensive knowledge of research involving the medical benefits of cannabis and its cannabinoids for pain management, medicinal and therapeutic use. He is a widely recognized academic expert on medical cannabis/cannabinoids and its many health benefits, and is also involved in several community service initiatives including his service on the State of Vermont's Marijuana Oversight Committee. Dr. McSherry is the author of numerous academic and public presentations on the medical use of cannabis/cannabinoids in general and as it relates to cancer and other specific medical conditions. He received theOutstanding Physician Advocate Award from the Washington, D.C.-based Marijuana Policy Project in 2010.

Dr. Michelle Sexton who is a highly-respected expert in the medicinal applications of cannabis, naturopathic medicine and the phytochemistry of plant medicine, with more than 15 years of experience in natural, herbal and holistic medicine. She currently serves as the Executive Medical Research Director at the Center for the Study of Cannabis and Social Policy in Seattle. For the past several years, she owned and operated Phytalytics LLC, doing business as PhytaLab, a phytochemical analysis company dedicated to developing and perfecting analytical platforms for the quality control of medical and adult use cannabis and related products in Washington state.

Dr. Mark Wallace is an acclaimed anesthesiologist specializing in pain management, with deep experience researching innovative pain treatments and performing in-depth clinical trials on all types of pain. He is board certified in both anesthesiology and pain medicine in the State of California, and is on faculty at the University of California San Diego Health System and the Veterans Affairs San Diego Healthcare System. At UC San Diego, Dr. Wallace serves as the chair of the Division of Pain Medicine and is a Professor of Clinical Anesthesiology. He is also the Director, Division of Clinical Research, UCSD Clinical and Translational Research Institute. He is actively involved in all aspects of clinical care, graduate medical education/training and research. Dr. Wallace's research on pain medicine has been widely published in an extensive array of peer-reviewed medical journals and books. He is also the recipient of numerous grants, including grants from Pfizer, Medtronic and Abbott Laboratories.

Dr. Fischedick is a respected expert in the therapeutic and medicinal properties of chemical components of plants, specifically Cannabis. He brings years of experience in advanced chromatography and spectrometry, including proven abilities in the isolation of natural products for scientific and medical analysis. Dr. Justin Fischedick is currently a Postdoctoral Research Associate at the Institute of Biological Chemistry at Washington State University, and has authored or co-authored several scientific articles on Cannabis, cannabinoids and terpenoids published in top scientific and medical journals. He has presented his scientific research at a number of national and international conferences including the Phytochemical Society of North America conference, the International Conference on Natural Products Research and the International Association for Cannabinoids as Medicine (IACM) conference.


* On June 4th they held their Inaugural Meeting of its Scientific/Medical Advisory Board to share expertise and insights on the benefits of CBD-based medicinal products, and develops product development plan. The advisory board is responsible for guiding the formulation of the proprietary line of natural Cannabidiol (CBD)-based nutritional supplements the company is developing in partnership with Terra Tech Corp. (TRTC).

Here are the results and comments from that inaugural meeting that everyone NEEDS to review, because it will give you a clear direction of where this company is headed in the medical MJ industry, spoken from these experts on this advisory board:

Together with Inergetics' CEO Mike James, CMO Jim Kras and Chief Science Officer, Carl Germano, RD, CNS, CDN, the group discussed the numerous health benefits of CBD and how they may best be delivered to patients. The meeting also produced a consensus on the next steps toward the development of CBD-based products.

"We are making clear progress in the development of superior CBD-based products that will offer a natural and workable remedy to patients seeking relief from a range of symptoms," said Carl Germano. "Certain cannabinoids are non-psychoactive, and proven to provide safe and effective relief to those suffering from pain, nausea, neurological disorders and other ailments. I could not have been more pleased with the substance of our discussion, and the plan we have devised for bringing our first CBD product to market."

Advisory Board member Dr. Joseph McSherry, M.D., a Neurologist and widely recognized academic expert on medical marijuana and its many health benefits, said, "An effort such as this is unprecedented. We have come so far since I first started advocating for the medicinal applications of Cannabis, and I am excited about working with this impressive group of colleagues to bring the therapeutic properties of CBD-based supplements to the consumers who could most benefit from them."

"Cannabinoids undoubtedly provide relief from pain and its underlying symptoms, and do so with far fewer side effects than other treatments currently available," said Dr. Mark Wallace, M.D., a member of the Advisory Board and the Chair of the Division of Pain Medicine at University of California San Diego. "CBD is a clear and essential alternative remedy for patients, and I think we are all eager to make this resource available to the public, and at a higher-quality."

Advisory Board member Dr. Michelle Sexton, a certified naturopathic doctor, said, "I look forward to working with this impressive group to take the first critical look at the proper dosage, potency, purity and methods of administration of cannabinoids. Right now there is no clear industry standard, and this team has an opportunity to change that."

"Twenty-five percent of drugs in the market today come from natural sources. Cannabis is just another one of those natural sources that can be used to help patients," said Justin Fischedick, PhD, a member of the Advisory Board and an expert in plant chemistry.

Dr. Yu Shao, Advisory Board member and also a consultant for Merck, added, "Inergetics and Terra Tech can help define the future of medicinal Cannabis, and I am pleased to be a part of this effort."

The strategic partnership between Inergetics and Terra Tech Corp was announced on February 4 and the companies' first CBD-based supplements are expected to be distributed via medicinal marijuana dispensaries. Inergetics announced the formation of the Scientific/Medical Advisory Board on March 5.


Continuing updates on the work of the Advisory Board and on the CBD product initiative will be available at http://www.inergetics.com/cbd-initiative/.


NOW THAT IS WHAT IS REALLY HAPPENING HERE AND EACH AND EVERY THING I POSTED IS FACTUAL AND TAKEN FROM TRUSTED VERIFIABLE SOURCES THAT I WILL PROVIDE TO ANY WHO REQUEST IT. MY OPINIONS EXPRESSED ARE BASED ON THESE FACTS AND OTHERS AND SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, BUT RATHER AS INFORMATIONAL ONLY. EVERYONE IS URGED TO DO THEIR OWN DD AND MAKE THEIR OWN INVESTING DECISIONS AFTER WEIGHING THE RISK.

DISCLOSURE: I AM LONG WITH 755,000 SHARES

I wish everyone here the very best and I stand firmly by opinion that the this CBD competitive advantage through this partnership between NRTI and TRTC will come into play when they go to market with the products they create with the help and endorsement from these experts on their Scientific/Medical Advisory Board. I see this as the biggest catalyst to drive the share price back up to where it belongs, above $.30, in the short term. In the long term I believe NRTI will be trading above $1.00 per share. Cheers!